Provide innovative critical information regarding the unique natural history of glycemic control, insulin sensitivity, and ß-cell function, and their mechanistic determinates, in obese adolescents at risk for developing type 2 diabetes.
Study Details
Internal Title:
24-148 - DISCOVERY
PCH IRB Number:
S-IRB-24-148
Clinical Trials Government Identifier:
NCT06525259
Diagnoses & Treatments:
Overweight, Obese, Dysglycemia
Study Type:
Other
Eligibility:
Age 9-13 year for girls, 10-14 year for boys, Overweight or obesity with BMI =85th percentile, Elevated HbA1c 5.5-6.4%
Enrollment Status:
Open
Phase:
Other